Pregled bibliografske jedinice broj: 1139188
Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia
Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia // Journal of chemotherapy, 30 (2018), 3; 189-191 doi:10.1080/1120009x.2018.1452585 (međunarodna recenzija, članak, stručni)
CROSBI ID: 1139188 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report
from Croatia
(Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections – the first report from Croatia)
Autori
Mareković, Ivana ; Bošnjak, Zrinka ; Jurić, Karla ; Ćorić, Mario ; Popović-Grle, Sanja
Izvornik
Journal of chemotherapy (1120-009X) 30
(2018), 3;
189-191
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
Escherichia coli ; extended spectrum beta-lactamases ; guidelines ; nitroxoline ; uncomplicated urinary tract infections
Sažetak
Nitroxoline (NTX), 5-nitro-8-hydroxyquinoline is an oral antibiotic with mechanism of bacteriostatic activity that is based on chelation of divalent cations required for bacterial RNA polymerase. Susceptibility to NTX of 100 Escherichia coli urine isolates was determined at the Department of Clinical and Molecular Microbiology, University Hospital Centre Zagreb during September and October 2017. Antimicrobial susceptibility was tested by disc diffusion and the results were interpreted according to the European Committee for Antimicrobial Susceptibility Testing (EUCAST) standards. All E. coli isolates, including ESBL-positive ones, were fully susceptible to imipenem, meropenem, amikacin, fosfomycin and NTX. This is the first report from Croatia about sensitivity of E. coli isolates to NTX. Besides fosfomycin, NTX was the only antimicrobial drug available for peroral administration demonstrating the sensitivity for all tested isolates. The results of the study demonstrated the potential of NTX as an additional therapeutically applicable option for the treatment of uncomplicated UTI.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za plućne bolesti "Jordanovac",
Klinički bolnički centar Zagreb
Profili:
Ivana Mareković
(autor)
Mario Ćorić
(autor)
Sanja Popović-Grle
(autor)
Zrinka Bošnjak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE